Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
Elisabetta Degasperi, Alessio AghemoDivision of Gastroenterology and Hepatology, AM and M Migliavacca Center, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, ItalyAbstract: In recent years, clinical research in the field of new treatments for chronic hepatitis C (...
Saved in:
Main Authors: | Degasperi E, Aghemo A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/d4444966b31d429fb2606060cfb123db |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
by: Naylor PH, et al.
Published: (2017) -
Interferon-free combination therapies for the treatment of hepatitis C: current insights
by: Holmes JA, et al.
Published: (2015) -
Hepatitis C in Argentina: epidemiology and treatment
by: Gaite LA, et al.
Published: (2014) -
Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
by: Sundaram V, et al.
Published: (2016) -
Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
by: Lim TR
Published: (2014)